TRIB - Trinity Biotech's COVID-19 antibody test OK'd in Europe

Trinity Biotech (TRIB) gains 10% in premarket after receiving CE Mark approval and registration for its Covid-19 IgG ELISA antibody test, the Captia SARS-CoV-2 IgG ELISA.The test uses a recombinant form of coronavirus spike protein to detect IgG antibodies, the detection of which indicate either past exposure to the virus or the desired immune response following vaccination.The company says that this is in addition to the launch of the product in the US following submission under the FDA Emergency Use Authorization pathway.

For further details see:

Trinity Biotech's COVID-19 antibody test OK'd in Europe